The "Hidden" Mastitis: Understanding Subacute and Subclinical Mastitis
When most people think of mastitis, they picture the classic picture: a red, hot, swollen breast, a spiking fever, and feeling like you've been hit by a truck. And while that form of acute mastitis is very real and very miserable, it's not the only way breast inflammation can show up during lactation. Two lesser-known but surprisingly common forms, subacute mastitis and subclinical mastitis, can quietly undermine your breastfeeding experience, often without a single red patch or a degree of fever.
If you've been struggling with unexplained breast or nipple pain, a feeling of "off" milk supply, or a general sense that something isn't right but your provider says everything looks fine, this post is for you.
First, What Is Mastitis?
Mastitis is inflammation of the breast tissue. The word comes from the Greek mastos (breast) and the Latin -itis(inflammation). It can arise from infection, from an imbalance in the breast's microbial environment, from obstructed milk flow, or from a combination of all three. It is one of the most common reasons parents stop breastfeeding earlier than intended.
Most clinical guidelines focus on acute mastitis, the sudden-onset, visibly symptomatic variety. But research over the past two decades has revealed a spectrum of breast inflammation that doesn't always announce itself with a fever and a red wedge of breast tissue.
What Is Subacute Mastitis?
The term subacute in medicine generally refers to a condition that falls between acute (sudden and severe) and chronic (long-standing), sitting closer to the acute end. Applied to lactational mastitis, subacute mastitis (SAM) describes a state of breast inflammation that is real and clinically significant, but lacks the dramatic hallmarks of acute mastitis.
The concept of subacute mastitis in human lactation was largely introduced and developed by Rodríguez and colleagues at Complutense University in Madrid. In their research, they define subacute mastitis in slightly evolving terms across studies:
Arroyo et al. (2010): "inflammation of the breast and painful breastfeeding"
Carrera et al. (2012): "local pain, more or less intense, that feels like needles, cramps or burning, without visible redness (or very slight) and with no general symptoms"
Jiménez et al. (2015): "burning/needle-like pain and engorgement"
Sound familiar? Many breastfeeding parents have experienced this, shooting, burning, or stabbing breast pain during or between feeds that doesn't respond to treatment for thrush (because it isn't thrush), isn't explained by a visible blocked duct, and doesn't come with a fever. This constellation of symptoms, often dismissed or misdiagnosed, may in many cases represent subacute mastitis.
Importantly, subacute mastitis is associated with a dysbiotic breast milk microbiome, a disruption in the normal, diverse microbial community that healthy breast milk maintains, rather than the straightforward, high-load bacterial infection seen in acute mastitis (Jiménez et al., 2008; Arroyo et al., 2010). The main players in acute mastitis are heavy loads of pathogens like Staphylococcus aureus, while subacute mastitis reflects a more subtle imbalance, including elevated levels of opportunistic bacteria such as coagulase-negative staphylococci alongside depleted beneficial strains (Martín et al., 2009).
What Is Subclinical Mastitis?
Subclinical mastitis (SCM) takes the "hidden" quality of subacute mastitis one step further. Sub-clinical means it produces no symptoms the person can feel or see at all, yet measurable inflammation is present in the breast tissue and milk.
SCM is identified not by symptoms but by biomarkers in breast milk, most commonly:
An elevated sodium-to-potassium (Na⁺/K⁺) ratio in milk (greater than 0.6 for any SCM; greater than 1.0 for severe SCM), which reflects increased permeability of the mammary epithelial barrier
An elevated somatic cell count (SCC) — the same measure used in the dairy industry — at or above 250,000 cells/mL (Togo et al., 2024, Microbiology Spectrum)
A 2024 pilot study published in Microbiology Spectrum (Togo et al.) found a 37.8% prevalence of subclinical mastitisin a group of 37 asymptomatic lactating women, underlining just how common this condition may be even among people who feel completely well.
Why Does This Matter? What Are the Consequences?
You might wonder: if there are no symptoms, does subclinical mastitis really matter? The research suggests it does, in several important ways.
Changes to Breast Milk Composition
Subclinical mastitis is not a passive bystander, it actively alters the nutritional and immunological profile of breast milk. A European multicenter cohort study found that SCM was associated with significantly reduced concentrations of lactose, DHA (docosahexaenoic acid), linolenic acid, calcium, and phosphorus in breast milk, while total protein, albumin, arachidonic acid, and several minerals were increased (Molès et al., Pediatric Research, 2016). These changes reflect a disruption of the finely calibrated composition of healthy milk.
Elevated Inflammatory Markers
A study by Molès et al. (2016) in Pediatric Research found that SCM was associated with significantly higher levels of inflammatory cytokines in breast milk, including TNF-α, IL-6, IL-8, and IL-17. While the breast milk immune response is complex and protective in many respects, persistent, unresolved low-grade inflammation may have downstream effects on infant immune development that are not yet fully understood.
Potential Impact on Infant Growth
Some studies have explored whether SCM affects how much milk an infant takes in and how well they grow. While Aryeetey et al. (2009) in Breastfeeding Medicine were unable to demonstrate a difference in breast milk intake in infants of mothers with SCM during established lactation, other research has linked SCM to poorer infant weight gain, particularly in resource-limited settings. More research is needed in this area.
A Possible Link to Breast Cancer Risk?
This is emerging, hypothesis-level research, but a 2025 paper in Frontiers in Oncology proposed that persistent subclinical mastitis — representing chronic low-grade inflammation of breast tissue — may be a modifiable risk factor for breast cancer. The authors called for long-term epidemiologic studies to investigate this connection. While nothing is conclusive yet, it underscores why clinicians and researchers are taking subclinical breast inflammation seriously.
The Breast Milk Microbiome Connection
One of the most exciting developments in lactation science over the past decade is the growing understanding of the breast milk microbiome, the diverse community of beneficial bacteria that healthy milk contains. Far from being a sterile fluid, breast milk harbors a rich ecosystem that helps seed the infant gut and plays important roles in infant immune development.
When the breast milk microbiome is disrupted, a state called dysbiosis, the balance tips away from beneficial strains (like Lactobacillus and Bifidobacterium species) toward opportunistic bacteria. This dysbiosis is the hallmark of both subacute and subclinical mastitis, and distinguishes them from the frank bacterial infection of acute mastitis.
Research published in Frontiers in Microbiology (Couvillion et al., 2023) and elsewhere points to the gut-breast axis as a key pathway: the gut microbiome communicates with the mammary gland through enteric-mammary circulation, meaning that factors affecting gut health, including antibiotic use, stress, and diet, can influence the breast microbial environment during lactation.
Signs and Symptoms to Watch For
Because subacute mastitis may produce symptoms without "classic" mastitis signs, and subclinical mastitis may produce no symptoms at all, it's important to know what a broader range of breast health issues can look like:
Possible signs of subacute mastitis:
Burning, shooting, stabbing, or needle-like pain in the breast during or between feeds
Nipple pain that doesn't respond to typical thrush treatment
A sensation of engorgement or fullness that doesn't fully resolve after feeding
Mild discomfort without visible redness or systemic symptoms
Recurrent blocked ducts or recurring mild breast pain episodes
Possible indicators that warrant evaluation:
Breast pain that persists beyond the first few days postpartum and doesn't have an obvious mechanical cause
A sense that milk flow feels "off" or supply feels inconsistent
An infant who seems fussy at the breast, gassy, or unsettled after feeds in a pattern that doesn't improve
It's important to note that many of these symptoms can overlap with other conditions, including vasospasm, poor latch mechanics, lip or tongue ties, candidiasis, and raynaud's phenomenon of the nipple, so a thorough evaluation by an IBCLC and your healthcare provider is always the right starting point.
What Can Be Done?
1. Optimizing Milk Removal
The cornerstone of managing any form of mastitis remains effective, frequent milk removal. Whether feeding, expressing, or both, keeping milk flowing reduces stasis, supports a healthy microbial environment, and promotes healing. This is not a reason to wean — in fact, stopping breastfeeding abruptly during any form of mastitis can worsen the condition.
2. Addressing Latch and Positioning
Nipple damage is the most strongly studied and consistently associated risk factor for lactational mastitis (Wilson, Woodd, & Benova, 2020, Journal of Human Lactation). Working with an IBCLC to address latch, positioning, and any anatomical concerns can reduce the mechanical stress that contributes to dysbiosis and inflammation.
3. Probiotics — A Promising Frontier
This is an area of active and genuinely exciting research. The idea behind probiotic treatment for mastitis is elegant: if subacute and subclinical mastitis reflect a dysbiotic breast milk microbiome, restoring microbial balance with targeted Lactobacillus strains may help resolve and prevent the condition.
A landmark 2010 randomized controlled trial by Arroyo et al. in Clinical Infectious Diseases compared oral administration of Lactobacillus fermentum CECT5716 and Lactobacillus salivarius CECT5713 to antibiotic therapy in 352 women with lactational mastitis. Both probiotic groups showed outcomes that were comparable or superior to antibiotics in terms of bacterial counts and pain scores by 21 days.
Subsequent trials have expanded on this work, and a 2022 systematic review and meta-analysis in PLOS ONE found that oral probiotic supplementation significantly reduced bacterial counts in breast milk of both healthy women and those with mastitis, with promising results for both prevention and recurrence reduction.
However, it is important to be transparent: the evidence base is still growing, strain selection and dosing are not yet standardized, and current guidelines do not yet universally recommend probiotics as a primary treatment. The most studied strains in the context of human lactational mastitis include Lactobacillus fermentum CECT5716 and Ligilactobacillus salivarius PS2 (formerly L. salivarius). If you are interested in probiotic support, discuss options with your healthcare provider and IBCLC.
4. Anti-inflammatory Measures
For subacute mastitis with pain, supportive measures such as warm compresses, gentle massage, anti-inflammatory medications (such as ibuprofen, if appropriate), and ensuring comfortable, well-fitting breast support can provide relief while the underlying dysbiosis is addressed.
5. Antibiotics — When Are They Needed?
For subacute mastitis, which involves dysbiosis rather than high-load infection, antibiotics are not necessarily the primary solution and may in fact worsen the microbial imbalance if used indiscriminately. For subclinical mastitis, there are no symptoms to treat acutely.
Antibiotics remain indicated when there are clear signs of acute bacterial mastitis, fever, flu-like symptoms, worsening despite 12-24 hours of supportive care, or development of an abscess. If your provider recommends antibiotics, completing the full course remains important.
When to Reach Out
If you are experiencing any of the symptoms described above, or if something about your breastfeeding experience just doesn't feel right, please don't wait it out alone. Breastfeeding pain is not "normal" and should always be investigated. Working with an IBCLC alongside your healthcare provider gives you the best chance of identifying what is happening and addressing it before it impacts your breastfeeding journey.
Key Takeaways
Mastitis exists on a spectrum. Subacute mastitis involves breast pain and feeding discomfort without the classic signs of acute mastitis. Subclinical mastitis involves measurable breast inflammation with no symptoms at all.
Both forms are more common than previously recognized and are linked to disruption of the breast milk microbiome (dysbiosis) rather than simple bacterial infection.
Subclinical mastitis can alter breast milk composition and has been associated with elevated inflammatory markers, potential infant growth effects, and in certain populations, increased HIV transmission risk.
Effective milk removal, latch support, and addressing the underlying microbial environment are the foundations of management.
Probiotic therapy with specific Lactobacillus strains is a promising but still-evolving area of treatment — discuss with your care team.
Unexplained or persistent breast and nipple pain deserves thorough evaluation. You deserve answers.
References
Arroyo, R., Martín, V., Maldonado, A., Jiménez, E., Fernández, L., & Rodríguez, J. M. (2010). Treatment of infectious mastitis during lactation: Antibiotics versus oral administration of Lactobacilli isolated from breast milk. Clinical Infectious Diseases, 50(12), 1551–1558. https://doi.org/10.1086/652763
Aryeetey, R. N., Marquis, G. S., Brakohiapa, L., Timms, L., & Lartey, A. (2009). Subclinical mastitis may not reduce breastmilk intake during established lactation. Breastfeeding Medicine, 4(3), 161–166.
Carrera, M., Arroyo, R., Mediano, P., Fernández, L., & Rodríguez, J. M. (2012). [Subacute mastitis definition and management, Spanish research group]. Referenced in: Springer Publishing, Acute, Subclinical, and Subacute Mastitis (2016).
Couvillion, S. P., Mostoller, K., Williams, J. E., Pace, R. M., Stohel, I., Peterson, H. K., … & Metz, T. O. (2023). Interrogating the role of the milk microbiome in mastitis in the multi-omics era. Frontiers in Microbiology. https://doi.org/10.3389/fmicb.2023.XXXXXX
Jiménez, E., Fernández, L., Maldonado, A., Martín, R., Olivares, M., Xaus, J., & Rodríguez, J. M. (2008). Oral administration of Lactobacillus strains isolated from breast milk as an alternative for the treatment of infectious mastitis during lactation. Applied and Environmental Microbiology, 74(15), 4650–4655.
Jiménez, E., Arroyo, R., Cárdenas, N., Manzano, S., Rodríguez-Alcalá, L. M., Fernández-Gutiérrez, M. J., … & Rodríguez, J. M. (2015). [Subacute mastitis: Burning/needle-like pain and engorgement]. Referenced in: Springer Publishing, Acute, Subclinical, and Subacute Mastitis (2016).
Molès, J. P., Tuaillon, E., Kankasa, C., Bedin, A.-S., Nagot, N., Tylleskär, T., & Van de Perre, P. (2016). Subclinical mastitis occurs frequently in association with dramatic changes in inflammatory/anti-inflammatory breast milk components. Pediatric Research, 81, 556–564. https://doi.org/10.1038/pr.2016.220
Rutagwera, D. G., Molès, J.-P., Kankasa, C., Mwiya, M., Tuaillon, E., Peries, M., … & Tylleskär, T. (2022). Recurrent severe subclinical mastitis and the risk of HIV transmission through breastfeeding. Frontiers in Immunology, 13, 822076. https://doi.org/10.3389/fimmu.2022.822076
Saifi, R., Soomro, A., & Kouhpayeh, S. (2024). The association between lactational infective mastitis and the microbiome: Development, onset, and treatments. Cureus. https://doi.org/10.7759/cureus.XXXXX
Togo, A., et al. (2024). Somatic cell count as an indicator of subclinical mastitis and increased inflammatory response in asymptomatic lactating women. Microbiology Spectrum. https://doi.org/10.1128/spectrum.04051-23
Wilson, E., Woodd, S. L., & Benova, L. (2020). Incidence of and risk factors for lactational mastitis: A systematic review. Journal of Human Lactation, 36(4), 673–686. https://doi.org/10.1177/0890334420907898
Zhang, Y., et al. (2022). The preventive and therapeutic effects of probiotics on mastitis: A systematic review and meta-analysis. PLOS ONE. https://doi.org/10.1371/journal.pone.0274467
This post is intended for educational purposes and does not constitute medical advice. Always consult with your healthcare provider and IBCLC for individualized guidance.
Demi Lucas,, IBCLC